Why Investors Should be Insulted Over Bayer AG's $40 Billion Offer for Monsanto
Last week, news broke that Bayer had made a $40 billion offer for agricultural technology leader Monsanto (NYSE:MON). That figure represented only a 10% premium to the company's market cap at the time and remains significantly lower than the $60 billion value assigned by the market before commodities prices tanked in late 2014. But you know what they say: "Buy low."